WRBY

$25.071.87%0.46

Warby Parker Inc (WRBY)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$24.61

Aprire:

$24.56

Volume 24 ore:

396,890

Volume relativo:

0.16

Capitalizzazione di mercato:

$3.10B

Reddito:

$890.57M

Utile/perdita netta:

$1.35M

Rapporto P/E:

2,638.95

EPS:

$0.0095

Flusso di cassa netto:

$38.90M

1W Prestazione:

-0.83%

1M Prestazione:

-7.25%

6M Prestazione:

+8.62%

1Y Prestazione:

+27.97%

Intervallo 1D:

$24.25$25.68

Intervallo di 1 settimana:

$23.84$25.57

Portata 52W:

$14.96$31.00

Profilo aziendale di Warby Parker Inc (WRBY)

Nome

Warby Parker Inc

Settore

Healthcare

Industria

Medical Instruments & Supplies

Telefono

(646) 847-7215

Indirizzo

233 SPRING STREET, NEW YORK, USA

Dipendente

4,036

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

SEC

Discussioni di WRBY su X

Confronta WRBY con ISRG, BDX, ALC, RMD, WST

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WRBY Warby Parker Inc	$3.10B	$890.57M	$1.35M	$38.90M	$0.0095
ISRG Intuitive Surgical Inc	$154.56B	$11.03B	$3.16B	$3.22B	$8.73
BDX Becton Dickinson Co	$53.89B	$21.37B	$1.41B	$3.07B	$3.94
ALC Alcon Inc	$35.18B	$10.63B	$819.00M	$1.59B	$1.66
RMD Resmed Inc	$32.50B	$5.54B	$1.52B	$1.74B	$10.37
WST West Pharmaceutical Services Inc	$28.84B	$3.22B	$542.70M	$458.00M	$7.48

Warby Parker Inc Azioni (WRBY) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-06-29	Iniziato	BofA Securities	Buy
2026-05-08	Reiterato	Telsey Advisory Group	Outperform
2025-12-10	Aggiornamento	Citizens JMP	Mkt Perform → Mkt Outperform
2025-11-07	Reiterato	Telsey Advisory Group	Outperform
2025-08-01	Reiterato	Telsey Advisory Group	Outperform
2025-07-10	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
2025-04-30	Aggiornamento	Citigroup	Sell → Neutral
2025-04-17	Aggiornamento	Loop Capital	Hold → Buy
2025-02-28	Reiterato	Telsey Advisory Group	Outperform
2025-02-25	Iniziato	ROTH MKM	Neutral
2025-02-05	Downgrade	Citigroup	Neutral → Sell
2025-01-17	Downgrade	Evercore ISI	Outperform → In-line
2024-11-19	Reiterato	Telsey Advisory Group	Outperform
2024-11-08	Reiterato	Telsey Advisory Group	Outperform
2024-11-07	Aggiornamento	William Blair	Mkt Perform → Outperform
2024-10-21	Aggiornamento	Goldman	Neutral → Buy
2024-08-23	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2024-08-23	Resumed	Piper Sandler	Overweight
2023-10-12	Aggiornamento	BTIG Research	Neutral → Buy
2023-10-03	Aggiornamento	Evercore ISI	In-line → Outperform
2023-09-25	Iniziato	UBS	Neutral
2023-06-27	Iniziato	William Blair	Mkt Perform
2023-05-24	Iniziato	JMP Securities	Mkt Perform
2023-03-01	Downgrade	Citigroup	Buy → Neutral
2023-02-07	Iniziato	BTIG Research	Neutral
2022-12-15	Iniziato	Wolfe Research	Outperform
2022-07-22	Iniziato	Piper Sandler	Overweight
2022-05-18	Downgrade	Goldman	Buy → Neutral
2022-03-31	Iniziato	Stifel	Hold
2021-10-26	Iniziato	Citigroup	Buy
2021-10-25	Iniziato	Cowen	Outperform
2021-10-25	Iniziato	Evercore ISI	In-line
2021-10-25	Iniziato	Goldman	Buy
2021-10-25	Iniziato	Morgan Stanley	Equal-Weight
2021-10-25	Iniziato	Robert W. Baird	Outperform
2021-10-25	Iniziato	Telsey Advisory Group	Outperform

Warby Parker Inc Azioni (WRBY) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	871.91	771.32	669.77	598.11	540.80
Cost of revenue USD (M)	401.33	344.48	304.54	257.05	223.05
Gross profit USD (M)	470.58	426.83	365.22	341.06	317.75
Operating expenses USD (M)	-	-	437.22	452.27	461.41
Operating income USD (M)	-5.34	-30.11	-72.00	-111.20	-143.66
Income before tax USD (M)	3.04	-19.52	-62.76	-109.90	-144.01
Income tax expense USD (M)	1.40	0.88	0.43	0.50	0.26
Net income USD (M)	1.64	-20.39	-63.20	-110.39	-144.27
Basic EPS USD/shares	0.01	-0.17	-0.54	-0.96	-2.21
Diluted EPS USD/shares	0.01	-0.17	-0.54	-0.96	-2.21
Basic weighted shares shares (M)	122.67	120.39	117.39	114.94	71.25
Diluted weighted shares shares (M)	125.10	120.39	117.39	114.94	71.25
Selling, general and administrative USD (M)	475.92	456.95	437.22	452.27	461.41

Warby Parker Inc Azioni (WRBY) insider trading

JEFFREY RAIDEROct 01 '26
Director
Transazione
Proposed Sale
Costo
$27.78
#Azioni
15,000
Valore ($)
416,700
#Azioni Totale
0
NEIL BLUMENTHALOct 01 '26
Director
Transazione
Proposed Sale
Costo
$27.78
#Azioni
100,000
Valore ($)
2,778,000
#Azioni Totale
0
Blumenthal Neil HarrisOct 01 '26
Co-Chief Executive Officer
Transazione
Sale
Costo
$27.69
#Azioni
100,000
Valore ($)
2,769,000
#Azioni Totale
36,020
Blumenthal Neil HarrisSep 02 '26
Co-Chief Executive Officer
Transazione
Option Exercise
Costo
$0.00
#Azioni
20,798
Valore ($)
0
#Azioni Totale
51,910
Gilboa David AbrahamSep 02 '26
Co-Chief Executive Officer
Transazione
Option Exercise
Costo
$0.00
#Azioni
20,798
Valore ($)
0
#Azioni Totale
51,910
Blumenthal Neil HarrisJul 06 '26
Co-Chief Executive Officer
Transazione
Sale
Costo
$29.99
#Azioni
9,200
Valore ($)
275,908
#Azioni Totale
31,112
DAVID GILBOAJul 06 '26
Director
Transazione
Proposed Sale
Costo
$29.26
#Azioni
54,347
Valore ($)
1,590,193
#Azioni Totale
0
NEIL BLUMENTHALJul 06 '26
Director
Transazione
Proposed Sale
Costo
$29.26
#Azioni
9,200
Valore ($)
269,192
#Azioni Totale
0
Gilboa David AbrahamJul 06 '26
Co-Chief Executive Officer
Transazione
Sale
Costo
$29.84
#Azioni
54,347
Valore ($)
1,621,714
#Azioni Totale
31,112
JEFFREY RAIDERJul 01 '26
Director
Transazione
Proposed Sale
Costo
$30.34
#Azioni
22,500
Valore ($)
682,650
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
JEFFREY RAIDER	Director	Oct 01 '26	Proposed Sale	$27.78	15,000	416,700	0
NEIL BLUMENTHAL	Director	Oct 01 '26	Proposed Sale	$27.78	100,000	2,778,000	0
Blumenthal Neil Harris	Co-Chief Executive Officer	Oct 01 '26	Sale	$27.69	100,000	2,769,000	36,020
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 02 '26	Option Exercise	$0.00	20,798	0	51,910
Gilboa David Abraham	Co-Chief Executive Officer	Sep 02 '26	Option Exercise	$0.00	20,798	0	51,910
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 06 '26	Sale	$29.99	9,200	275,908	31,112
DAVID GILBOA	Director	Jul 06 '26	Proposed Sale	$29.26	54,347	1,590,193	0
NEIL BLUMENTHAL	Director	Jul 06 '26	Proposed Sale	$29.26	9,200	269,192	0
Gilboa David Abraham	Co-Chief Executive Officer	Jul 06 '26	Sale	$29.84	54,347	1,621,714	31,112
JEFFREY RAIDER	Director	Jul 01 '26	Proposed Sale	$30.34	22,500	682,650	0

Warby Parker Inc Borsa (WRBY) Ultime notizie

Oct 30, 2026

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains - Zacks Investment Research

Oct 30, 2026

Oct 27, 2026

Press Release: Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026 - 富途牛牛

Oct 27, 2026

Warby Parker stock price target reiterated at $34 by BTIG - Investing.com Nigeria

Oct 27, 2026

Warby Parker stock price target reiterated at $34 by BTIG - Investing.com Canada

Oct 27, 2026

What is a Public Benefit Corporation? Anthropic's Unusual Legal Status and What It Means for Investors - The Motley Fool

Oct 27, 2026

Oct 24, 2026

Warby Parker - Class A Share News - Latest Updates, Live News & More - scanx.trade

Oct 24, 2026

Oct 23, 2026

Form 144 Warby Parker Inc. For: 18 October By Investing.com - Investing.com Australia

Oct 18, 2026

Oct 15, 2026